152 related articles for article (PubMed ID: 31222839)
21. [Establishment of a new scirrhous gastric cancer cell line OCUM-2M from a primary gastric tumor].
Yashiro M; Chung YS; Nishimura S; Yamada N; Sawada T; Kubo T; Nakata B; Sowa M
Nihon Shokakibyo Gakkai Zasshi; 1995 Mar; 92(3):199-205. PubMed ID: 7731088
[TBL] [Abstract][Full Text] [Related]
22. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
23. Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.
Matsuoka T; Hirakawa K; Chung YS; Yashiro M; Nishimura S; Sawada T; Saiki I; Sowa M
Clin Exp Metastasis; 1998 May; 16(4):381-8. PubMed ID: 9626817
[TBL] [Abstract][Full Text] [Related]
24. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
25. Frequent amplification of the c-met gene in scirrhous type stomach cancer.
Kuniyasu H; Yasui W; Kitadai Y; Yokozaki H; Ito H; Tahara E
Biochem Biophys Res Commun; 1992 Nov; 189(1):227-32. PubMed ID: 1333188
[TBL] [Abstract][Full Text] [Related]
26. Novel models for human scirrhous gastric carcinoma in vivo.
Takemura S; Yashiro M; Sunami T; Tendo M; Hirakawa K
Cancer Sci; 2004 Nov; 95(11):893-900. PubMed ID: 15546507
[TBL] [Abstract][Full Text] [Related]
27. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
[TBL] [Abstract][Full Text] [Related]
28. Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer.
Iwauchi T; Tanaka H; Yamazoe S; Yashiro M; Yoshii M; Kubo N; Muguruma K; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2011 Apr; 102(4):683-9. PubMed ID: 21205089
[TBL] [Abstract][Full Text] [Related]
29. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma.
Nishimura S; Chung YS; Yashiro M; Inoue T; Sowa M
Br J Cancer; 1996 Nov; 74(9):1406-12. PubMed ID: 8912536
[TBL] [Abstract][Full Text] [Related]
30. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
31. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
[TBL] [Abstract][Full Text] [Related]
32. [Genetic characteristics of scirrhous gastric carcinomas].
Yokozaki H; Kuniyasu H; Yasui W; Tahara E
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2371-7. PubMed ID: 7944479
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
34. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells.
Nishimura S; Chung YS; Yashiro M; Inoue T; Sowa M
Jpn J Cancer Res; 1996 Dec; 87(12):1235-44. PubMed ID: 9045958
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor.
Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Oshima T; Yanagihara K; Oue N; Yasui W
Pathobiology; 2014; 81(3):138-48. PubMed ID: 24642718
[TBL] [Abstract][Full Text] [Related]
36. Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer.
Murahashi K; Yashiro M; Inoue T; Nishimura S; Matsuoka T; Sawada T; Sowa M; Hirakawa-Ys Chung K
Int J Oncol; 1998 Dec; 13(6):1235-40. PubMed ID: 9824637
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice.
Fujita T; Yanagihara K; Takeshita F; Aoyagi K; Nishimura T; Takigahira M; Chiwaki F; Fukagawa T; Katai H; Ochiya T; Sakamoto H; Konno H; Yoshida T; Sasaki H
Cancer Sci; 2013 Feb; 104(2):214-22. PubMed ID: 23106787
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
[TBL] [Abstract][Full Text] [Related]
40. Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer.
Yasumoto M; Sakamoto E; Ogasawara S; Isobe T; Kizaki J; Sumi A; Kusano H; Akiba J; Torimura T; Akagi Y; Itadani H; Kobayashi T; Hasako S; Kumazaki M; Mizuarai S; Oie S; Yano H
Cancer Med; 2017 Jan; 6(1):235-244. PubMed ID: 27891760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
